Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Mar 2026 is -13.98% vs 11.15% in Mar 2025
Consolidate Net Profit
YoY Growth in quarter ended Mar 2026 is 13.04% vs 9.52% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Mar 2026 is 7.14% vs 16.67% in Mar 2025
Interest
YoY Growth in quarter ended Mar 2026 is -10.00% vs 25.00% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
Compare Quarterly Results Of Biogened SA With
Quarterly - Net Sales
QoQ Growth in quarter ended Mar 2026 is 0.35% vs 18.99% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -13.98% vs 11.15% in Mar 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 188.89% vs 0.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 13.04% vs 9.52% in Mar 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Mar 2026 is 122.22% vs 80.00% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 7.14% vs 16.67% in Mar 2025
Quarterly - Interest
QoQ Growth in quarter ended Mar 2026 is 350.00% vs -66.67% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -10.00% vs 25.00% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025






